Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy. [electronic resource]
By: Contributor(s):- Frison, Vera
- Bettio, Michela
- Dal Pos, Michela
- Rocchini, Paola
- Panebianco, Giuseppe
- Tadiotto, Federica
- Da Tos, Virgilio
- D'Ambrosio, Michele
- Marangoni, Alberto
- Ferrari, Maria
- Pianta, Alessandro
- Balzano, Sara
- Confortin, Loris
- Lamonica, Mario
- Marin, Narciso
- Strazzabosco, Marco
- Brun, Elisabetta
- Mesturino, Chiara Alberta
- Simoncini, Maria
- Zen, Francesco
- Bax, Giuseppe
- Bonsembiante, Barbara
- Cardone, Claudio
- Dal Frà, Maria Grazia
- Gallo, Alessandra
- Masin, Michela
- Piarulli, Francesco
- Sartore, Giovanni
- Simioni, Natalino
- 1879-114X
- Aged
- Blood Glucose -- drug effects
- Body Mass Index
- Body Weight
- Diabetes Mellitus, Type 2 -- drug therapy
- Female
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemic Agents -- therapeutic use
- Insulin -- therapeutic use
- Italy
- Lipids -- blood
- Liraglutide -- therapeutic use
- Male
- Metformin -- therapeutic use
- Middle Aged
- Retrospective Studies
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
-
21
Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.
by Dodart, Jean-Cosme -
22
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis.
by Castellano, Joseph M -
23
The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice.
by Fryer, John D -
24
Challenges, solutions, and recommendations for Alzheimer's disease combination therapy.
by Hendrix, James A -
25
ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.
by DeMattos, Ronald B -
26
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.
by Morikawa, Masayuki -
27
A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.
by Liang, Yu -
28
Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice.
by Lemere, Cynthia A -
29
In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
by Cirrito, John R -
30
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.
by Bateman, Randall J -
31
Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies.
by Lachno, D Richard -
32
A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.
by Demattos, Ronald B -
33
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease.
by Farlow, Martin -
34
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques.
by Wang, Yaming -
35
ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo.
by Burgess, Braydon L -
36
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.
by Castellano, Joseph M -
37
The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein.
by Tansley, Gavin H -
38
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
by Honig, Lawrence S -
39
Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.
by Racke, Margaret M -
40
Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
by Wang, Hong
Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
APA
Lapolla A., Frison V., Bettio M., Dal Pos M., Rocchini P., Panebianco G., Tadiotto F., Da Tos V., D'Ambrosio M., Marangoni A., Ferrari M., Pianta A., Balzano S., Confortin L., Lamonica M., Marin N., Strazzabosco M., Brun E., Mesturino C. A., Simoncini M., Zen F., Bax G., Bonsembiante B., Cardone C., Dal Frà M. G., Gallo A., Masin M., Piarulli F., Sartore G. & Simioni N. (20160329). Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy. : Clinical therapeutics.
Chicago
Lapolla Annunziata, Frison Vera, Bettio Michela, Dal Pos Michela, Rocchini Paola, Panebianco Giuseppe, Tadiotto Federica, Da Tos Virgilio, D'Ambrosio Michele, Marangoni Alberto, Ferrari Maria, Pianta Alessandro, Balzano Sara, Confortin Loris, Lamonica Mario, Marin Narciso, Strazzabosco Marco, Brun Elisabetta, Mesturino Chiara Alberta, Simoncini Maria, Zen Francesco, Bax Giuseppe, Bonsembiante Barbara, Cardone Claudio, Dal Frà Maria Grazia, Gallo Alessandra, Masin Michela, Piarulli Francesco, Sartore Giovanni and Simioni Natalino. 20160329. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy. : Clinical therapeutics.
Harvard
Lapolla A., Frison V., Bettio M., Dal Pos M., Rocchini P., Panebianco G., Tadiotto F., Da Tos V., D'Ambrosio M., Marangoni A., Ferrari M., Pianta A., Balzano S., Confortin L., Lamonica M., Marin N., Strazzabosco M., Brun E., Mesturino C. A., Simoncini M., Zen F., Bax G., Bonsembiante B., Cardone C., Dal Frà M. G., Gallo A., Masin M., Piarulli F., Sartore G. and Simioni N. (20160329). Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy. : Clinical therapeutics.
MLA
Lapolla Annunziata, Frison Vera, Bettio Michela, Dal Pos Michela, Rocchini Paola, Panebianco Giuseppe, Tadiotto Federica, Da Tos Virgilio, D'Ambrosio Michele, Marangoni Alberto, Ferrari Maria, Pianta Alessandro, Balzano Sara, Confortin Loris, Lamonica Mario, Marin Narciso, Strazzabosco Marco, Brun Elisabetta, Mesturino Chiara Alberta, Simoncini Maria, Zen Francesco, Bax Giuseppe, Bonsembiante Barbara, Cardone Claudio, Dal Frà Maria Grazia, Gallo Alessandra, Masin Michela, Piarulli Francesco, Sartore Giovanni and Simioni Natalino. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy. : Clinical therapeutics. 20160329.